- Home
- HTLD vs RFL Comparison
HTLD vs RFL Comparison
Compare HTLD & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- RFL
- Stock Information
- Founded
- HTLD 1978
- RFL 2017
- Country
- HTLD United States
- RFL United States
- Employees
- HTLD N/A
- RFL N/A
- Industry
- HTLD Trucking Freight/Courier Services
- RFL Real Estate
- Sector
- HTLD Industrials
- RFL Finance
- Exchange
- HTLD Nasdaq
- RFL Nasdaq
- Market Cap
- HTLD N/A
- RFL 48.4M
- IPO Year
- HTLD N/A
- RFL N/A
- Fundamental
- Price
- HTLD $9.00
- RFL $1.42
- Analyst Decision
- HTLD Sell
- RFL
- Analyst Count
- HTLD 3
- RFL 0
- Target Price
- HTLD $10.00
- RFL N/A
- AVG Volume (30 Days)
- HTLD 734.1K
- RFL 131.5K
- Earning Date
- HTLD 07-22-2025
- RFL 06-13-2025
- Dividend Yield
- HTLD 0.89%
- RFL N/A
- EPS Growth
- HTLD N/A
- RFL N/A
- EPS
- HTLD N/A
- RFL N/A
- Revenue
- HTLD $996,611,000.00
- RFL $706,000.00
- Revenue This Year
- HTLD N/A
- RFL N/A
- Revenue Next Year
- HTLD $7.04
- RFL N/A
- P/E Ratio
- HTLD N/A
- RFL N/A
- Revenue Growth
- HTLD N/A
- RFL 156.73
- 52 Week Low
- HTLD $7.11
- RFL $1.27
- 52 Week High
- HTLD $13.67
- RFL $2.47
- Technical
- Relative Strength Index (RSI)
- HTLD 56.05
- RFL 47.80
- Support Level
- HTLD $8.87
- RFL $1.28
- Resistance Level
- HTLD $9.13
- RFL $1.41
- Average True Range (ATR)
- HTLD 0.22
- RFL 0.08
- MACD
- HTLD 0.01
- RFL 0.02
- Stochastic Oscillator
- HTLD 74.58
- RFL 66.67
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.